Actively Recruiting

Phase 1
Age: 18Years - 75Years
All Genders
NCT06907628

A Trial of SHR-3792 Injection in Patients With Advanced Solid Tumors

Led by Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Updated on 2025-04-25

150

Participants Needed

1

Research Sites

95 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The study is being conducted to evaluate the safety, tolerability, pharmacokinetics and preliminary efficacy of SHR-3792 injection monotherapy for patients with advanced solid tumors, and to explore the reasonable dosage of SHR-3792 injection monotherapy for patients with advanced solid tumors.

CONDITIONS

Official Title

A Trial of SHR-3792 Injection in Patients With Advanced Solid Tumors

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Able to understand and agree to participate by signing informed consent
  • Have unresectable recurrent or metastatic solid tumors
  • Have at least one measurable tumor lesion
  • Have an ECOG performance status score of 0 or 1
  • Have adequate organ function as defined by the study
  • Have a life expectancy of 3 months or more
Not Eligible

You will not qualify if you...

  • Have active central nervous system metastases
  • Have had another malignancy within the past 5 years
  • Have tumor-related pain that cannot be controlled
  • Have serious cardiovascular or cerebrovascular diseases
  • Have uncontrollable third-space effusions such as pleural, pericardial, or peritoneal effusion
  • Have severe infections
  • Have a history of immunodeficiency or autoimmune diseases
  • Have an active infection
  • Are pregnant or nursing
  • Have a known history of serious allergic reactions to the study drug or its main ingredients

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Shandong First Medical University Affiliated Cancer Hospital

Jinan, Shandong, China, 250117

Actively Recruiting

Loading map...

Research Team

F

Fangfang Peng

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here